Johannesburg- and London-listed Thungela Resources delivered a resilient performance for the financial year ended December 31 ...

Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...